ABIOMED, Inc. (ABMD) financial statements (2020 and earlier)

Company profile

Business Address 22 CHERRY HILL DR
DANVERS, MA 01923
State of Incorp. DE
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11812136223021213277
Cash and cash equivalents1181214339482221
Short-term investments  31919116411056
Receivables101917054433224
Inventory, net of allowances, customer advances and progress billings91815035271714
Inventory91815035271714
Other undisclosed current assets3263841287403
Total current assets:637677494327288220118
Noncurrent Assets
Property, plant and equipment162145117882397
Long-term investments and receivables  384711442
Long-term investments  384711442
Intangible assets, net (including goodwill)48485346484638
Goodwill33333631333238
Intangible assets, net (excluding goodwill)151517141515 
Other noncurrent assets13585148441
Deferred tax assets, net7871355945 
Other undisclosed noncurrent assets21522     
Total noncurrent assets:56037729222313611887
TOTAL ASSETS:1,1971,054786550424338205
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities103907058385039
Accounts payable323224219108
Accrued liabilities72574638282218
Employee-related liabilities     1612
Taxes payable     21
Deferred revenue19
Debt   1   
Deferred revenue and credits1510975
Contract with customer, liability16
Other liabilities4      
Other undisclosed current liabilities     (17)(13)
Total current liabilities:1261068570473930
Noncurrent Liabilities
Long-term debt and lease obligation   16   
Capital lease obligations  16   
Liabilities, other than long-term debt23111213977
Deferred tax liabilities, net111116
Other liabilities12113000
Business combination, contingent consideration, liability101010987
Other undisclosed noncurrent liabilities1      
Total noncurrent liabilities:23111229977
Total liabilities:1501179798554737
Stockholders' equity
Stockholders' equity attributable to parent1,047937690452369292168
Common stock0000000
Treasury stock, value(240)(139)(67)(47)(27)(19)(17)
Additional paid in capital733691620566509465436
Accumulated other comprehensive loss(17)(15)(4)(21)(15)(17)(1)
Retained earnings (accumulated deficit)571399140(47)(99)(137)(251)
Total stockholders' equity:1,047937690452369292168
TOTAL LIABILITIES AND EQUITY:1,1971,054786550424338205

Income statement (P&L) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Revenues841769594445330230184
Revenue, net 445330230184
Cost of revenue(147)(130)(99)(71)(50)(42)(39)
Cost of goods and services sold(147)(130)(4)(71)(50)(42)(39)
Gross profit:695640495375279188144
Operating expenses(438)(415)(338)  (162)(138)
Other undisclosed operating income (loss)   (285)(214)22
Operating income:2572251579065298
Nonoperating income593931100
Investment income, nonoperating12842000
Other nonoperating income (expense)4830(0)(0)0(0)0
Other undisclosed loss from continuing operations before equity method investments, income taxes   (0)   
Income from continuing operations before equity method investments, income taxes:3162631609166299
Other undisclosed income from continuing operations before income taxes   0   
Income from continuing operations before income taxes:3162631609166299
Income tax expense (benefit)(71)(4)(48)(39)(28)85(1)
Net income available to common stockholders, diluted:24525911252381147

Comprehensive Income ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Net income:24525911252381147
Other comprehensive income (loss)(5)(10)16(6)3(17)3
Comprehensive income, net of tax, attributable to parent:24024912946419710

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: